FDA.reportPublic FDA data

COPOVIDONE K25-31

Substance profile for UNII D9C330MD8B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
D9C330MD8B
Preferred term
COPOVIDONE K25-31
Registry number
25086-89-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
0
PubChem
0
NCIt
C80921
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
NCI ThesaurusC80921ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80921
FDA Substance Registration SystemD9C330MD8Bprecision.fda.gov/uniisearch/srs/unii/D9C330MD8B

DailyMed Socrata Ingredients#

Ingredient, DailyMed label, SPL version table
IngredientDailyMed labelSPL version
PVP/VA COPOLYMERBurberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen SPF20 Warm Nude No. 342
COPOVIDONEGABAPENTIN2
COPOVIDONEDRUG FACTS2
COPOVIDONE K25-31Diclofenac Sodium Extended-release Tablets8
PVP/VA COPOLYMERGood Neighbor Pharmacy Itch Relief1
COPOVIDONE K25-31CITALOPRAM HYDROBROMIDE3
COPOVIDONE K25-31Burberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen Broad Spectrum SPF 15 Mocha No.643
COPOVIDONE K25-31Guaifenesin ER Tabs1
COPOVIDONE K25-31Burberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen Broad Spectrum SPF 20 Ochre No.202
COPOVIDONE K25-31DICLOFENAC SODIUM1
COPOVIDONETOC Kit finalCopy of Tox Kit 2(Importer)Tox Kit (Importer)refence productsThese highlights do not include all the information needed to use Toxicology Saliva Collection Kit safely and effectively.see full prescribing information for Toxicology Saliva Collection KitToxicology Saliva Collection Kit (Toxicology Saliva Collection Kit) KIT for ORAL use.Initial U.S. Approval:These highlights do not include all the information needed to use Toxicology Saliva Collection Kit safely and effectively.see full prescribi6
COPOVIDONETemporary Fibromyalgia Pain and Discomfort Relief® Homeopathic Fast Dissolving Tablets1
copovidoneThese highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 20122
COPOVIDONECitalopram Tablets, USP Rx Only4
COPOVIDONE K25-31Citalopram Hydrobromide Tablets, USP1
COPOVIDONE K25-31These highlights do not include all the information needed to use oxcarbazepine oral suspension, USP safely and effectively. See full prescribing information for oxcarbazepine oral suspension, USP. Oxcarbazepine oral suspension, USP for oral administration Initial U.S. Approval: 20008
COPOVIDONE K25-31Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
Copovidone K25-31These highlights do not include all the information needed to use fenofibric acid tablets safely and effectively. See full prescribing information for fenofibric acid tablets. Fenofibric Acid Tablets, for oral use Initial U.S. Approval: 19938
Copovidone K25-31These highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 19932
COPOVIDONE K25-31Citalopram Tablets USP4
COPOVIDONEDrug Facts2
COPOVIDONE K25-31e6c92a3f-e194-4f28-bd8c-e1794cd6f4481
COPOVIDONE K25-31Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx only4
COPOVIDONEMigraine Headache Therapy™ Homeopathic Fast Dissolving Tablets2
COPOVIDONE K25-31Citalopram Tablets, USP1
COPOVIDONECitalopram Tablets, USP Rx Only5
COPOVIDONEDrug Facts1
PVP/VA COPOLYMERDrug Facts1
PVP/VA COPOLYMERDrug Facts2
COPOVIDONE K25-31ProStat Bandage Spray2
COPOVIDONEFexofenadine HCl and Pseudoephedrine HCI ER Tablets USP 180240 mg1
COPOVIDONE K25-31LidoPatch™3
COPOVIDONE K25-31Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
COPOVIDONEArthritis Therapy Homeopathic Fast Dissolving Tablets1
COPOVIDONEGabapentin Tablets, USP 600 mg and 800 mg Allied Pharma Inc5
COPOVIDONE K25-31FERROUS SULFATE ENTERIC-COATED TABLETS3
COPOVIDONEDrug Facts1
COPOVIDONE K25-31Gabapentin Tablets USP2
PVP/VA COPOLYMERYOUR LOGO HERE POISON IVY RELIEF1
copovidone K25-31These highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 199313
COPOVIDONE K25-31Axe AntiDandruff Styling Cream1
COPOVIDONE K25-317d8c8762-e491-4798-8866-0db6425308e82
COPOVIDONEDrug Facts1
Copovidone K25-31Citalopram Tablets USP1
Copovidone K25-31Citalopram Tablets USP1
Copovidone K25-31Citalopram Tablets USP1
PVP/VA COPOLYMER2a00e54c-b302-42eb-a192-a2af5f420a4b1
COPOVIDONE K25-31FERROUS SULFATE ENTERIC-COATED TABLETS2
COPOVIDONEChronic Fatigue Therapy™ Homeopathic Fast Dissolving Tablets1
COPOVIDONE K25-31These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONE K25-31These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONE K25-31Gabapentin Tablets, USP3
COPOVIDONEDrug Facts2
COPOVIDONEDrug Facts1
COPOVIDONEALLEGRA-D ® 24 HOUR (fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg) Extended-Release Tablets2
COPOVIDONEDrug Facts1
COPOVIDONEDrug Facts1
copovidoneEstradiol/Norethindrone Acetate Tablets1
COPOVIDONEBuPROPion hydrochloride extended-release tablets, USP (SR)1
COPOVIDONE K25-31BuPROPion hydrochloride extended-release tablets, USP (SR)4
COPOVIDONE K25-319f5a14c2-b460-402e-acb4-04402278e64b2
COPOVIDONE K25-31531112e5-db64-457d-af7d-baa86f2bcec22
COPOVIDONE K25-31Gabapentin Tablets USP3
COPOVIDONE K25-31These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
COPOVIDONE K25-31These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONECitalopram Tablets, USP5
COPOVIDONEThese highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet for Oral use Initial U.S. Approval: 19952
COPOVIDONE K25-31Citalopram Tablets USP1
COPOVIDONE K25-31Gabapentin Tablets USP4
COPOVIDONEGLYBURIDE and METFORMIN HYDROCHLORIDE TABLETS USP Rx only1
COPOVIDONE K25-31Citalopram Tablets, USP1
COPOVIDONE33694be4-87ce-4d25-92f6-6ae517bdf5ff1
COPOVIDONEBuPROPion hydrochloride extended-release tablets, USP (SR)1
copovidoneFENTANYL TRANSDERMAL SYSTEM CII1
COPOVIDONEThese highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
Copovidone K25-31CVS ® pharmacy COLD REMEDY PLUS FAST MELTING1
COPOVIDONECitalopram Tablets, USP1
COPOVIDONESentralopram AM-109
COPOVIDONE56bf1b0a-463a-4324-957b-585d4cf352ee1
COPOVIDONEGLYBURIDE and METFORMIN HYDROCHLORIDE TABLETS USP Rx only 5710 5711 57121
COPOVIDONEHydrocone Bitartrate and Acetaminophen1
COPOVIDONEThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
copovidoneThese highlights do not include all the information needed to use ROZEREM safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablet, film coated for oral use Initial U.S. Approval: 20051
COPOVIDONEdrug facts2
COPOVIDONEDrug Facts CVS Congestion Relief DM1
CopovidoneRITE AID ® PHARMACY1
CopovidoneRITE AID ® PHARMACY1
COPOVIDONE2f45060b-ce5c-4869-87c0-fd7d2224e86c2
COPOVIDONEIbuprofen Tablets, USP1
COPOVIDONE5ac5271e-316c-4802-a172-aa602d22571f1
copovidoneLevetiracetam Tablets1
copovidoneFexofenadine HCl and Pseudoephedrine HCl5
COPOVIDONEf738ddad-fef0-43cb-b791-b046fdcec3111
COPOVIDONE9fb17714-bdb1-4bfa-bc04-d9c011604cde1
COPOVIDONECitalopram Tablets, USP1
COPOVIDONECitalopram Tablets, USP1
COPOVIDONE5caff592-a90f-420d-a6ec-9b2dc914529e2
COPOVIDONE7a51d289-2013-4d37-adf2-91ea49df79321
COPOVIDONE741e8b74-2bb5-4153-9727-92ad91e9e9a01
COPOVIDONECitalopram Tablets, USP2
COPOVIDONEIbuprofen Tablets, USP2
COPOVIDONECITALOPRAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3973
copovidoneCELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC ]3225
COPOVIDONEROZEREM TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3168
COPOVIDONEGABAPENTIN TABLET [LAKE ERIE MEDICA & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3163
COPOVIDONE K25-31KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
COPOVIDONE K25-31NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
COPOVIDONEKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
COPOVIDONE K25-31FENTANYL PATCH [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31GLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31GLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31GLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31GRALISE (GABAPENTIN) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]203
COPOVIDONECITALOPRAM HYDROBROMIDE TABLET, FILM COATED [REMEDYREPACK INC. ]148
COPOVIDONEMETFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]58
COPOVIDONECARVEDILOL TABLET [REMEDYREPACK INC. ]56
COPOVIDONE K25-31TECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]53
COPOVIDONEETODOLAC (ETODOLAC) TABLET [REMEDYREPACK INC. ]39
COPOVIDONE K25-31CITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]31

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII D9C330MD8B page 1 of 1 · 16 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
COPOVIDONE K25-31D9C330MD8B25086899CAPSULEORAL1346 mg
COPOVIDONE K25-31D9C330MD8B25086899CAPSULE, COATED PELLETSORAL88 mg
COPOVIDONE K25-31D9C330MD8B25086899CAPSULE, DELAYED RELEASEORAL199 mg
COPOVIDONE K25-31D9C330MD8B25086899CAPSULE, EXTENDED RELEASEORAL200 mg
COPOVIDONE K25-31D9C330MD8B25086899PELLETORAL1653 mg
COPOVIDONE K25-31D9C330MD8B25086899POWDER, FOR SUSPENSIONORAL5917 mg
COPOVIDONE K25-31D9C330MD8B25086899SUSPENSIONORAL172 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLETORAL6374 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, CHEWABLEORAL5 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, DELAYED RELEASEORAL168 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, EXTENDED RELEASEORAL300 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, FILM COATEDORAL5917 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, FILM COATED, EXTENDED RELEASEORAL53 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLET, ORALLY DISINTEGRATINGORAL35 mg
COPOVIDONE K25-31D9C330MD8B25086899TABLETSUBLINGUAL54 mg
COPOVIDONE K25-31D9C330MD8B25086899FILM, EXTENDED RELEASETRANSDERMALNA